Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionCapital Fund Management S.a.
Latest Disclosed Ownership126,429 shares
Latest Disclosed Value $ 5,096,352
Capital Fund Management S.a. reports 29.46% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 14, 2026 - Capital Fund Management S.a. filed a 13F-HR form disclosing ownership of 126,429 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $4,360,536 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 97,660 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 29.46% during the quarter. The current value of the position is $7,995,370 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F CORCEPT THERAPEUTICS INC COM CORCEPT THERAPEUTICS INC COM 218352102 126,429 28,769 29.46 5,096 49.97 0.0230
2026-02-17 2025-12-31 13F CORCEPT THERAPEUTICS INC COM CORCEPT THERAPEUTICS INC COM 218352102 97,660 -62,784 -39.13 3,399 -74.52 0.0094
2025-11-13 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 160,444 76,015 90.03 13,334 115.17 0.0349
2025-08-13 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 84,429 -23,710 -21.93 6,197 -49.83 0.0171
2025-05-14 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 108,139 -12,867 -10.63 12,352 102.58 0.0356
2025-02-13 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 121,006 -28,991 -19.33 6,097 -12.16 0.0156
2024-11-13 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 149,997 56,100 59.75 6,942 127.57 0.0190
2024-08-13 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 93,897 -39,282 -29.50 3,051 -9.06 0.0090
2024-05-15 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 133,179 55,342 71.10 3,355 32.67 0.0097
2024-02-14 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 77,837 12,637 19.38 2,528 42.34 0.0068
2023-11-14 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 65,200 52,020 394.69 1,776 506.14 0.0061
2023-08-14 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 13,180 -7 -0.05 293 2.81 0.0012
2023-05-15 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 13,187 -5,538 -29.58 286 -25.00 0.0014
2023-02-13 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 18,725 18,725 380 0.0026
2022-11-14 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 0 -18,594 -100.00 0 -100.00
2022-08-12 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 18,594 18,594 442 0.0040
2021-05-14 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 0 -25,965 -100.00 0 -100.00
2021-02-12 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 25,965 9,705 59.69 679 139.93 0.0064
2020-11-13 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 16,260 16,260 283 0.0035
2020-08-13 2020-06-30 13F Corcept Therapeutics COM 218352102 0 -10,172 -100.00 0 -100.00
2020-05-13 2020-03-31 13F Corcept Therapeutics COM 218352102 10,172 10,172 121 0.0019
2019-02-13 2018-12-31 13F Corcept Therapeutics COM 218352102 0 -540,818 -100.00 0 -100.00
2018-11-14 2018-09-30 13F Corcept Therapeutics COM 218352102 540,818 229,969 73.98 7,582 55.15 0.0413
2018-08-14 2018-06-30 13F Corcept Therapeutics COM 218352102 310,849 143,801 86.08 4,887 77.84 0.0255
2018-05-15 2018-03-31 13F Corcept Therapeutics COM 218352102 167,048 167,048 2,748 0.0165
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.